Turn Biotechnologies' Expanded eTurna™ Delivery Platform Designed to Solve Delivery and Targeting Issues that Challenge Industry

Turn Biotechnologies, Inc. California

Company announces development of novel ionizable lipids and stabilizing componentseTurna™ delivery platform expected to improve safety, reduce immunogenicityCustomizable platform can be optimized to treat variety of cells, tissues and organsPlatform can accommodate different routes of administration, cargoesView original content:https://www.prnewswire.co.uk/news-releases/turn-biotechnologies-expanded-eturna-delivery-platform-designed-to-solve-delivery-and-targeting-issues-that-challenge-industry-302024843.html